NeueHealth Inc (NYSE:NEUE) Reports Mixed Q2 2025 Results: Revenue Misses but EPS Beats Estimates NeueHealth Q2 2025 results: Revenue missed at $209.1M vs. $300.8M estimate, but EPS beat at -$1.68 vs. -$4.39. Adjusted EBITDA profitable for sixth straight quarter. Stock dipped slightly pre-market.
US Stocks To Open Higher On Shortened Trading Day: Santa Claus Rally Period Officially Begins, Says Analyst U.S. stock futures advanced on Tuesday, head of a shortened trading session owning to Christmas-eve. The stock market will shut at 1 p.m. ET.
NEUE Stock Earnings: NeueHealth Beats EPS, Misses Revenue for Q1 2024 NEUE stock results show that NeueHealth beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
NEUE Stock Earnings: NeueHealth Beats EPS, Beats Revenue for Q4 2023 NEUE stock results show that NeueHealth beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Earnings Scheduled For March 6, 2024 Companies Reporting Before The Bell • CTS (
NYSE:CTS ) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
